Investor Relations (IR) Event - Domestic NDR
- NDR for domestic institutional investors scheduled (2026-05-20~21, sponsored by Sangsangin Securities, 1:1 face-to-face meetings)
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: SK Biopharmaceuticals (326030)
- Submission: SK Biopharmaceuticals Co., Ltd.
- Receipt: 05-19-2026
- Under KRX KOSPI Market Division